Schroder Investment Management Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $979K | Hold |
48,099
| – | – | ﹤0.01% | 995 |
|
|
2025
Q1 | $959K | Hold |
48,099
| – | – | ﹤0.01% | 994 |
|
|
2024
Q4 | $1.21M | Hold |
48,099
| – | – | ﹤0.01% | 993 |
|
|
2024
Q3 | $1.6M | Hold |
48,099
| – | – | ﹤0.01% | 970 |
|
|
2024
Q2 | $1.78M | Hold |
48,099
| – | – | ﹤0.01% | 944 |
|
|
2024
Q1 | $2.02M | Hold |
48,099
| – | – | ﹤0.01% | 922 |
|
|
2023
Q4 | $1.91M | Buy |
+48,099
| New | +$1.91M | ﹤0.01% | 917 |
|
|
2014
Q4 | – | Sell |
-1,500
| Closed | -$292K | – | 1364 |
|
|
2014
Q3 | $292K | Hold |
1,500
| – | – | ﹤0.01% | 1143 |
|
|
2014
Q2 | $367K | Hold |
1,500
| – | – | ﹤0.01% | 1093 |
|
|
2014
Q1 | $398K | Hold |
1,500
| – | – | ﹤0.01% | 1101 |
|
|
2013
Q4 | $545K | Hold |
1,500
| – | – | ﹤0.01% | 1102 |
|
|
2013
Q3 | $797K | Buy |
+1,500
| New | +$797K | ﹤0.01% | 1044 |
|